Trial intelligence / Profile preview

Simplifying Rabies Pre-exposure Vaccination

NCT01388985Phase 3Completed

Sponsor
Institute of Tropical Medicine Antwerp
Start
Oct 2011
Primary completion
Jan 2016
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of rabies virus inactivated antigen, B in rabies, sponsored by Institute of Tropical Medicine Antwerp. Started Oct 2011; status: completed.

02

Drugs

rabies virus inactivated antigen, B
03

Conditions

rabies

Beyond the preview

Go deeper on NCT01388985.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01388985.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call